NLRP3 and Alzheimer disease: Furthermore, AD-MSCs promoted M2 macrophages in the synovial membrane, inhibited NLRP3 inflammasome, and induced anti-inflammatory cytokines, IL-10 or TGF-β, while decreasing NF-κB activity [85].